반응식
[CH3:1][C:2]1[CH:3]=[CH:4][C:5]([S:8](Cl)(=[O:10])=[O:9])=[N:6][CH:7]=1.[N:12]1[CH:17]=[CH:16][CH:15]=[CH:14][CH:13]=1>C(Cl)Cl>[N:12]1[C:17]2[C:16](=[CH:2][CH:3]=[CH:4][C:5]=2[NH:6][S:8]([C:5]2[CH:4]=[CH:3][C:2]([CH3:1])=[CH:7][N:6]=2)(=[O:10])=[O:9])[CH:15]=[CH:14][CH:13]=1참가 물질
4
실험 절차
In a similar fashion using route 14 general procedure 27, 8-aminoqunoline (40 mg, 0.27 mmol), 5-methyl-pyridine-2-sulfonyl chloride 440 (79 mg, 0.41 mmol), pyridine (1.5 ml) DMAP (cat.) and DCM (2 ml) gave the title compound (21 mg, 25%) after purification by column chromatography with n-hexane/EtOAc (93:7) as the eluent.
출처 및 근거
- ORD 기록
- ord-311fe6dc3e554d51b0a165ecd488016c
- 출처 데이터셋
- uspto-grants-2015_08
- 특허 번호
- US09102688B2
연결된 노트
불러오는 중…